Corneal crosslinking without epithelial removal
- 1 November 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 44 (11) , 1363-1370
Abstract
To evaluate the effect of riboflavin-ultraviolet (UV)-A corneal crosslinking (CXL) without epithelial removal on ectatic corneal disease. Woolfson Eye Institute, Atlanta, Georgia, USA. Prospective observational study. Patients were treated with a new riboflavin formulation without epithelial removal, then exposed to UV light (365 nm) at 4 mW/cm2 with on-off cycling for 30 minutes. Uncorrected (UDVA) and corrected (CDVA) distance visual acuities, maximum corneal curvature (maximum keratometry [Kmax]), total higher-order aberrations (HOAs), and coma were measured at 3, 6, 12, and 24 months postoperatively. Progression was defined as an increase of more than 1 diopter (D) in Kmax and loss of more than 1 line of CDVA. Five hundred twelve eyes of 308 patients with keratoconus or forme fruste keratoconus and 80 eyes of 55 patients with ectasia after laser in situ keratomileusis (LASIK) were treated with the new riboflavin formulation without epithelial removal; 229 patients received bilateral treatments, 95 of which were simultaneous. The mean UDVA and CDVA improved by 1 to 1.5 Snellen lines at 1 and 2 years postoperatively (P < .0001). Mean Kmax decreased by 0.48 D at 2 years postoperatively (P = .0002). Mean total HOAs and coma decreased by 36% (P < .0001) and 37% (P = .0002), respectively, at 2 years postoperatively. Kmax decreased more than 1 D in three times as many eyes as it increased more than 1 D (P < .0001). No eyes progressed, and there was no loss of effect between 1 and 2 years postoperatively. No vision-threatening events were observed. Pain typically resolved within 24 hours, and visual acuity returned to preoperative levels in 1 to 2 days. Epithelium-on CXL using this new protocol halted the progression of keratoconus and ectasia after LASIK. It was safer and provided more rapid visual recovery than CXL with epithelial removal, allowing routine bilateral, simultaneous treatment.Keywords
This publication has 38 references indexed in Scilit:
- Comparative Analysis of Refractive and Topographic Changes in Early and Advanced Keratoconic Eyes Undergoing Corneal Collagen CrosslinkingCornea, 2013
- Progression of Keratoconus and Efficacy of Corneal Collagen Cross-linking in Children and AdolescentsJournal of Refractive Surgery, 2012
- Photochemical Kinetics of Corneal Cross-Linking with RiboflavinInvestigative Ophthalmology & Visual Science, 2012
- Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: Scheimpflug and biomicroscopic analysisJournal of Cataract & Refractive Surgery, 2010
- Fusarium Keratitis 3 Weeks After Healed Corneal Cross-LinkingJournal of Refractive Surgery, 2010
- Complication and failure rates after corneal crosslinkingJournal of Cataract & Refractive Surgery, 2009
- Microbial keratitis after corneal collagen crosslinkingJournal of Cataract & Refractive Surgery, 2009
- Acanthamoeba keratitis with perforation after corneal crosslinking and bandage contact lens useJournal of Cataract & Refractive Surgery, 2009
- Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-AJournal of Cataract & Refractive Surgery, 2009
- Herpetic keratitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconusJournal of Cataract & Refractive Surgery, 2007